For commonly occurring low-risk stage III colon cancers, the NCCN guidelines have been updated with findings from the IDEA trial supporting 3 months of chemotherapy instead of 6 months.
Medscape Medical News
Original Article: Biggest Change Since 2004 in NCCN Colon Cancer Chemo Guide
NEXT ARTICLE